Home|DSIJArticleDetail

230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?
230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?

230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it?

The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years.

Siddharth Mane Article rating: 4.1

The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent.

Stocks to watch: These small-cap stocks will be in focus on Tuesday!
Stocks to watch: These small-cap stocks will be in focus on Tuesday!

Stocks to watch: These small-cap stocks will be in focus on Tuesday!

Among the BSE Smallcap gainers were Olectra Greentech, Rhi Magnesita India, Radhe Developers and Chemplast Sanmar.

Bhavya Rathod Article rating: 4.2

On Monday, the Sensex fell by 175 points to close at 59,288.35, while the Nifty 50 dropped by 73 points to close at 17,392.70

Overnight Digest: Stocks likely to be in focus on August 1
Overnight Digest: Stocks likely to be in focus on August 1

Overnight Digest: Stocks likely to be in focus on August 1

Keep an eye on these stocks for Monday's trading session

Shreya Chaware Article rating: 4.4

On Friday, investors piled up the metal and IT shares, coupled with some major Sensex stocks like Reliance Industries, HDFC twins, Sun Pharma, and Bajaj Finance. The benchmark indices ended the trading session near the day's high level, closing the week on a green note. 

Stocks to watch: These smallcap stocks will be in focus tomorrow!
Stocks to watch: These smallcap stocks will be in focus tomorrow!

Stocks to watch: These smallcap stocks will be in focus tomorrow!

Nahar Capital and Financial Services, Sree Rayalaseema Hi-Strength Hypo, Linde India, Excel Industries, Kothari Products, Nahar Poly Films, Polyplex Corporation and Supreme Petrochem made a fresh 52-week high today.  

Armaan Madhani Article rating: 4.4

BSE Smallcap index outperformed broader markets, losing only 0.88 per cent and closing at 26,987.85.

 

DSIJ MINDSHARE

Mkt Commentary17-May, 2024

Multibaggers19-May, 2024

Multibaggers18-May, 2024

Interviews18-May, 2024

Multibaggers17-May, 2024

Knowledge

General15-May, 2024

MF14-May, 2024

MF14-May, 2024

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual

View Registration Certificate

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual

View Registration Certificate

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP
BASL Membership ID: 1346

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Condition | Privacy Statement | WhiteList